Express Pharma

Natco launches Hepatitis B drug

3

The company is one of the first entities to launch the generic version of the drug under its brand Tafnat

Natco Pharma has launched a generic version of Tenofovir Alafenamide, a drug used to treat chronic Hepatitis B in the country. The company is one of the first entities to launch the generic version of the drug under its brand Tafnat, Natco Pharma said in a regulatory filing.

Natco is producing Tafnat under license from Medicines Patent Pool (MPP) and Gilead Sciences. The company said it has priced the medicine at Rs 1,900 for a monthly pack of 30 tablets for the Indian market.

Comments are closed.